作者
Shahin Isha, Ananya Vasudhar, Subekshya Khadka, Sadhana Jonna, Jorge Sinclair De Frias, Parthkumar Satashia, PRASANTH BALASUBRAMANIAN, ANNA JENKINS, ABBY HANSON, ARVIND BALAVENKATARAMAN, AYSUN TEKIN, VIKAS BANSAL, RAHUL KASHYAP, SYED ANJ KHAN, RICARDO DIAZ MILIAN, NEAL M PATEL, QUINTIN QUINONES, SEAN KILEY, ANIRBAN BHATTACHARYYA, ANNA B SHAPIRO, SANJAY CHAUDHARY, PRAMOD K GURU, PABLO MORENO FRANCO, DEVANG SANGHAVI
发表日期
2023/10/1
期刊
CHEST
卷号
164
期号
4
页码范围
A1806-A1807
出版商
Elsevier
简介
PURPOSE: Inhaled nitric oxide (iNO), a pulmonary vasodilator, has demonstrated beneficial effects in improving oxygenation among the ARDS population. However, the data regarding the extent to which the drug impacts hospital outcomes is conflicting. Our study explores nitric oxide therapy's effects based upon its initiation time.
METHODS: We performed a retrospective multi-center study analyzing COVID-19 patients admitted to the Mayo Clinic Enterprise health system between March 2020 and June 2022 who received iNO and were intubated during the same stay. Data were extracted from the Society of Critical Care Medicine VIRUS COVID-19 registry by automated data pull and retrospective chart review. Patients who received nitric oxide prior to intubation were included in the pre-intubation group and those who were initiated on nitric oxide while intubated, were included in the post-intubation group …
学术搜索中的文章
S Isha, A Vasudhar, S Khadka, S Jonna, JS De Frias… - CHEST, 2023